Skip to main content

Articles

Page 10 of 20

  1. Authors: Lisa C Costello-Boerrigter, Guido Boerrigter, Syed Ameenuddin, Douglas W Mahoney, Joshua P Susser, Denise M Heublein, Margaret M Redfield, Richard J Rodeheffer, Timothy M Olson and John C Burnett Jr
    Citation: BMC Pharmacology 2009 9(Suppl 1):P9

    This article is part of a Supplement: Volume 9 Supplement 1

  2. Regulators of G protein signaling (RGSs) accelerate GTP hydrolysis by Gα subunits and profoundly inhibit signaling by G protein-coupled receptors (GPCRs). The distinct expression patterns and pathophysiologic ...

    Authors: Rebecca A Roof, David L Roman, Samuel T Clements, Katarzyna Sobczyk-Kojiro, Levi L Blazer, Shodai Ota, Henry I Mosberg and Richard R Neubig
    Citation: BMC Pharmacology 2009 9:9
  3. Tuberous sclerosis complex (TSC) is an autosomal dominant tumor suppressor syndrome, characterized by hamartomatous growths in the brain, skin, kidneys, lungs, and heart, which lead to significant morbidity. T...

    Authors: Nancy Lee, Chelsey L Woodrum, Alison M Nobil, Aubrey E Rauktys, Michael P Messina and Sandra L Dabora
    Citation: BMC Pharmacology 2009 9:8
  4. While doxorubicin (DOX) is widely used in cancer chemotherapy, long-term severe cardiotoxicity limits its use. This is the first report of the chemoprotective efficacy of a relatively new thiol antioxidant, N-...

    Authors: Rong Shi, Chuan-Chin Huang, Robert S Aronstam, Nuran Ercal, Adam Martin and Yue-Wern Huang
    Citation: BMC Pharmacology 2009 9:7
  5. Diclofenac is a nonsteroidal anti-inflammatory drug which is available as prescription (RX) and over-the-counter (OTC) medication for the systemic and topical treatment of painful and inflammatory conditions s...

    Authors: A Schweitzer, N Hasler-Nguyen and J Zijlstra
    Citation: BMC Pharmacology 2009 9:5
  6. K+ and Na+ channel toxins constitute a large set of polypeptides, which interact with their ion channel targets. These polypeptides are classified in two different structural groups. Recently a new structural gro...

    Authors: Rima Soli, Belhassen Kaabi, Mourad Barhoumi, Mohamed El-Ayeb and Najet Srairi-Abid
    Citation: BMC Pharmacology 2009 9:4
  7. Pluripotency, the property of a cell to differentiate into all cellular types of a given organism, is central to the development of stem cell-based therapies and regenerative medicine. Stem cell pluripotency i...

    Authors: Luigi Adamo, Yuzhi Zhang and Guillermo García-Cardeña
    Citation: BMC Pharmacology 2009 9:2
  8. Allosteric modulation of membrane receptors is a widespread mechanism by which endogenous and exogenous agents regulate receptor function. For example, several members of the nicotinic receptor family are modu...

    Authors: James T McLaughlin, Sean C Barron, Jennifer A See and Robert L Rosenberg
    Citation: BMC Pharmacology 2009 9:1
  9. A series of 1H-imidazo- [4,5-c]quinolin-4-amine derivatives, represented by LUF6000 (N-(3,4-dichloro-phenyl)-2-cyclohexyl-1H-imidazo [4,5-c]quinolin-4-amine), are allosteric modulators of the human A3 adenosine r...

    Authors: Zhan-Guo Gao, Kai Ye, Anikó Göblyös, Adriaan P IJzerman and Kenneth A Jacobson
    Citation: BMC Pharmacology 2008 8:20
  10. The activator protein-1 (AP-1) family of transcription factors contributes to regulation of numerous genes involved in proliferation, apoptosis, and tumorigenesis. A wide array of stimuli can activate AP-1, in...

    Authors: Lorraine M Deck, Lucy A Hunsaker, Amanda M Gonzales, Robert A Orlando and David L Vander Jagt
    Citation: BMC Pharmacology 2008 8:19
  11. Authors: Claudia C Wagner, Marie Simpson, Graham Lappin, Rudolf Karch, Aiman Abrahim, Thomas Feurstein, Martin Bauer, Markus Zeitlinger, Kurt Kletter, Markus Müller and Oliver Langer
    Citation: BMC Pharmacology 2008 8(Suppl 1):A49

    This article is part of a Supplement: Volume 8 Supplement 1

  12. Authors: Walter A Kaufmann, Francesco Ferraguti, Yugo Fukazawa, Yu Kasugai, Ryuichi Shigemoto, Petter Laake, Joseph A Sexton, Peter Ruth, Georg Wietzorrek, Hans-Günther Knaus, Johan F Storm and Ole P Ottersen
    Citation: BMC Pharmacology 2008 8(Suppl 1):A37

    This article is part of a Supplement: Volume 8 Supplement 1